Local Bounti Corporation (NYSE: LOCL) received a formal non‑compliance notice from the New York Stock Exchange on February 5, 2026, and the notice was publicly disclosed on February 12, 2026. The exchange cited the company’s average global market capitalization and stockholders’ equity as falling below the $50 million thresholds required by Section 802.01B of the NYSE Listed Company Manual.
The notice grants Local Bounti a nine‑month cure period, during which the company must submit a plan to regain compliance within 45 days of receiving the notice. The exchange has stated that the notice does not immediately affect the company’s listing; shares will continue to trade on the NYSE while the cure period is in effect.
Local Bounti’s financial profile underscores the seriousness of the situation. In the third quarter of 2025, the company reported a 19% year‑over‑year revenue increase to $12.1 million, yet it still posted a net loss of $26.4 million, down from a $34.3 million loss the previous year. The company’s debt burden of $487.06 million and negative equity position, combined with an Altman Z‑Score of –2.12, place it in the distress zone. Market‑cap data show a steep decline from a peak of $556.93 million in 2021 to roughly $44.8 million in early February 2026, well below the $50 million minimum.
Management has indicated that it is exploring all available options to regain compliance, but it has not yet disclosed a specific strategy or timeline. The company has previously faced a similar notice on April 3, 2024, when it was granted an 18‑month cure period. The recurrence of these notices highlights a persistent challenge in meeting NYSE listing standards.
The broader business implications are significant. Persistent losses, high leverage, and a low market cap raise concerns about the company’s ability to access capital and maintain investor confidence. While the company is pursuing cost‑reduction initiatives that could generate $7 million in annualized savings and is targeting positive adjusted EBITDA early in 2026, the current financial position suggests that achieving the required market‑cap and equity thresholds will be difficult without a substantial turnaround or capital infusion.
The risk of delisting remains the primary market reaction driver. Investors are likely to view the notice as a warning sign of potential liquidity constraints and a possible erosion of shareholder value if the company fails to meet the cure period requirements.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.